Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,432,168
  • Shares Outstanding, K 84,933
  • Annual Sales, $ 2,407 M
  • Annual Income, $ 427,720 K
  • 60-Month Beta 0.81
  • Price/Sales 11.80
  • Price/Cash Flow 55.64
  • Price/Book 263.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 1.14
  • Number of Estimates 4
  • High Estimate 1.24
  • Low Estimate 0.89
  • Prior Year 1.43
  • Growth Rate Est. (year over year) -20.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
294.17 +13.80%
on 06/15/20
339.80 -1.48%
on 07/02/20
+18.28 (+5.78%)
since 06/02/20
3-Month
233.25 +43.52%
on 04/03/20
339.80 -1.48%
on 07/02/20
+95.06 (+39.66%)
since 04/02/20
52-Week
168.65 +98.49%
on 03/23/20
339.80 -1.48%
on 07/02/20
+57.75 (+20.85%)
since 07/02/19

Most Recent Stories

More News
IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.

DGX : 116.04 (+1.74%)
QGEN : 42.51 (-0.47%)
LH : 170.27 (+1.94%)
IDXX : 334.76 (+0.07%)
HOLX vs. IDXX: Which Stock Is the Better Value Option?

HOLX vs. IDXX: Which Stock Is the Better Value Option?

HOLX : 57.86 (+1.56%)
IDXX : 334.76 (+0.07%)
Idexx Labs Set to Possibly Rebound After Yesterday's Selloff of 1.89%

Idexx Labs (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $304.97 to a high of $311.07. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $306.69...

IDXX : 334.76 (+0.07%)
IDEXX OPTI Medical Gets CE Mark for RT-PCR Coronavirus Test

This test by IDEXX (IDXX) benefits from an optimized workflow and claims to deliver greater assurance of quality and accuracy.

ILMN : 373.10 (+1.23%)
QGEN : 42.51 (-0.47%)
IDXX : 334.76 (+0.07%)
APHA : 4.30 (-1.38%)
OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

, and , /PRNewswire/ --OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark certification in the European Union for its...

MDSY : 0.73 (+4.29%)
IDXX : 334.76 (+0.07%)
Look for Shares of Idexx Labs to Potentially Pullback after Yesterday's 1.02% Rise

Idexx Labs (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $307.19 to a high of $314.00. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $311.97...

IDXX : 334.76 (+0.07%)
The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%

, /PRNewswire/ -- The global veterinary point-of-care diagnostics market is projected to grow at a CAGR of 8.9% during the forecast year. Read the full report: The global veterinary point-of-care diagnostics...

FUJIY : 43.3416 (-0.34%)
IDXX : 334.76 (+0.07%)
ONEXF : 44.4300 (+7.09%)
ZTS : 137.66 (+0.34%)
The global veterinary imaging market is estimated to record a CAGR of 6.12% during the forecast period. 2019-2028

, /PRNewswire/ -- The global veterinary imaging market is estimated to record a CAGR of 6.12% during the forecast period. 2019-2028. The surge in pet ownership, innovation in veterinary imaging systems,...

AFGVF : 4.0098 (unch)
FUJIY : 43.3416 (-0.34%)
IDXX : 334.76 (+0.07%)
SIEGY : 59.4300 (+1.49%)
Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories

Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories

MYGN : 11.58 (+2.93%)
IDXX : 334.76 (+0.07%)
CNK : 12.27 (-4.36%)
VCEL : 15.11 (+1.61%)
IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis

IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.

OMI : 7.36 (-2.65%)
SRDX : 43.00 (+0.23%)
IDXX : 334.76 (+0.07%)
APHA : 4.30 (-1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IDXX with:

Business Summary

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff...

See More

Key Turning Points

2nd Resistance Point 342.65
1st Resistance Point 338.70
Last Price 334.76
1st Support Level 331.92
2nd Support Level 329.07

See More

52-Week High 339.80
Last Price 334.76
Fibonacci 61.8% 274.42
Fibonacci 50% 254.23
Fibonacci 38.2% 234.03
52-Week Low 168.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar